...
首页> 外文期刊>Journal of Krishna Institute of Medical Sciences University. >Mitigating Risk of COVID-19 Transmission at Antiretroviral Therapy (ART) Centres in India.
【24h】

Mitigating Risk of COVID-19 Transmission at Antiretroviral Therapy (ART) Centres in India.

机译:印度抗逆转录病毒治疗(艺术)中心的Covid-19传播风险。

获取原文

摘要

World Health Organization (WHO) declared novel Corona virus Disease of 2019 (COVID-19) outbreak as a pandemic and emphasized countries to take immediate actions on March 11, 2020 [1]. This disease has impacted everyone across the globe especially individuals with comorbid conditions. WHO had mentioned that People Living with HIV (PLHIV) who have not achieved viral suppression through antiretroviral treatment may have a compromised immune system that leaves them vulnerable to opportunistic infections and further disease progression [2]. There is a concern among HIV infected individuals for risk of acquiring Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) infections due to their immunocompromised status.
机译:世界卫生组织(世卫组织)宣布2019年(Covid-19)爆发的新型电晕病毒疾病是大流行和强调国家,以便于2020年3月11日立即采取行动[1]。这种疾病影响了全球各地的每个人,特别是具有合并条件的个体。谁已经提到通过抗逆转录病毒治疗没有取得病毒抑制的艾滋病毒(plhiv)的人可能具有受损的免疫系统,使他们容易受到机会性感染和进一步的疾病进展[2]。艾滋病毒感染的个体患有患有可获得严重急性呼吸综合征Corona病毒2(SARS-COV-2)感染的患者的担忧。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号